glp-1 and migraines Glucagon-like peptide-1 (GLP-1) receptor agonists for headache pain disorders: a systematic review | The Journal of Headache and Pain Have you had fewer migraines

analysis of treatment plans, including compounded GLP-1s, customers taking a compounded GLP-1 reported losing an average of 20.9 pounds or 10.3% of initial body weight, within six months, while reporting a low rate of side effects

PNA mice receiving BBR-containing (2 mg/ mouse per day) oral boiled peanut immunotherapy (BNP) demonstrated enduring tolerance to peanut with sustained reductions in IgE, plasma histamine, symptom scores including body temperature, and amount of IgE + B cells [52]

Unlike generic drugs, which are FDA-approved products brought to market after patents expire, compounded meds are meant to be substitutes offered for specific purposes, like drug shortages

Are these concerns something you should worry about

It acts as an insulator, a shock absorber, and a storage area for energy in the form of fat